Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Aromatherapy for Anxiety and Self-esteem: Clinical Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01963689
Recruitment Status : Completed
First Posted : October 16, 2013
Last Update Posted : October 16, 2013
Sponsor:
Information provided by (Responsible Party):
Juliana Rizzo Gnatta, University of Sao Paulo

Brief Summary:
The aim of this study was to determine whether the use of Ylang Ylang essential oil through dermal application or inhalation alters the perception of anxiety and self-esteem and physiological parameters such us blood pressure and temperature.

Condition or disease Intervention/treatment Phase
Anxiety Self Esteem Other: Intervention Group 2 Other: Intervention Group 1 Other: Intervention Group 3 Not Applicable

Detailed Description:
34 nurses from the University Hospital participated in this study and were randomized into three groups: one that received the Ylang Ylang Essential Oil cutaneous route, the second received the Essential Oil inhalation and the third (placebo) received the essence of Ylang ylang cutaneous route.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 34 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Aromatherapy for Anxiety and Self-esteem: Clinical Trial
Study Start Date : June 2012
Actual Primary Completion Date : September 2013
Actual Study Completion Date : September 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
Placebo Comparator: Intervention Group 2
Individuals belonging to Group 2 received a bottle containing aromatic gel enriched with ylang ylang essence only in 2% concentration and used massage with essential oil 3 times a day: leaving home to go to work, leaving the shift and before bedtime. The points indicated were the two handles and the sternum. Gel was applied and massaged in a circular motion for 30 seconds.
Other: Intervention Group 2
Massage with Ylang Ylang Essence was applied for 30 seconds on the handle and the sternum area
Other Names:
  • Massage
  • Aromatherapy

Experimental: Intervention Group 1
Individuals belonging to Group 1 received a bottle containing aromatic gel enriched with essential oil of ylang ylang in a concentration of 2% and used massage with essential oil 3 times a day: leaving home to go to work, leaving the shift and before bedtime. The points indicated were the two handles and the sternum. Gel was applied and massaged in a circular motion for 30 seconds.
Other: Intervention Group 1
Massage with Ylang Ylang essential oil in the wrist and in the region of the sternum
Other Names:
  • Massage
  • Aromatherapy

Experimental: Intervention Group 3
The subjects in Group 3 were responsible for before the beginning of their working, put a drop of essential oil of ylang ylang in cotton located within the freshener personal and should be used throughout your work shift
Other: Intervention Group 3
Put a drop of essential oil of ylang ylang in cotton located within the freshener and inhale throughout their work shift
Other Name: Aromatherapy




Primary Outcome Measures :
  1. State-Trait Anxiety Inventory [ Time Frame: after 60 days ]
    The State-Trait Anxiety Inventory consists of 2 scales, each one containing 20 items. One of the scales evaluates state anxiety, characterized by subjective feelings of tension and apprehension, followed by autonomic nervous system responses at a given moment. Trait anxiety, assessed by the other scale, refers to a relatively stable tendency to perceive situations at threatening and react anxiously to them. The scores are divided into low, moderate, high and very high and are determined by the sum of 20 symptoms from a 5-point Likert-type scale.The range of scores is 20-80, the higher the score indicating greater anxiety for both the Trait and State Anxiety.


Secondary Outcome Measures :
  1. Self-Esteem Scale [ Time Frame: after 60 days ]
    This is a unidimensional measure of self-esteem, which has 15 statements about the assessments that the subject makes about itself. For each statement, the subject chooses one of two options: agree or disagree. The level of self-esteem is provided through a template that assigns one point for each answer in agreement and zero points for each answer in disagreement. The maximum score is 15 points and the minimum is 0 points.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   34 Years to 53 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • be an employee of the nursing team and not be on probation
  • accept make use gel or freshener containing essential oil or essence ylang ylang
  • respond Anxiety Inventory(STAI)and Self-esteem scale and present moderate, high or very high anxiety on the STAI, medium or low self-esteem on the scale Self-esteem
  • accept not wear perfume during the survey period
  • accept the smell of Ylang Ylang.

Exclusion Criteria:

  • Self reported Hypotension
  • Medical License or vacation during the period

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01963689


Sponsors and Collaborators
University of Sao Paulo
Investigators
Layout table for investigator information
Principal Investigator: Maria Júlia P da Silva Nursing School of São Paulo University

Layout table for additonal information
Responsible Party: Juliana Rizzo Gnatta, University of Sao Paulo
ClinicalTrials.gov Identifier: NCT01963689    
Other Study ID Numbers: 469376
First Posted: October 16, 2013    Key Record Dates
Last Update Posted: October 16, 2013
Last Verified: October 2013
Keywords provided by Juliana Rizzo Gnatta, University of Sao Paulo:
Anxiety
Self-Esteem
Additional relevant MeSH terms:
Layout table for MeSH terms
Anxiety Disorders
Mental Disorders